{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:51:40Z","timestamp":1791172300764,"version":"4.1.0"},"reference-count":18,"publisher":"EDP Sciences","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1051\/medsci\/2003195613","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T17:51:58Z","timestamp":1299347518000},"page":"613-619","source":"Crossref","is-referenced-by-count":20,"title":["La maladie de Parkinson : que nous apprennent les g\u00e8nes responsables des formes familiales ?"],"prefix":"10.1051","volume":"19","author":[{"given":"Olga","family":"Corti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2003,5,15]]},"reference":[{"key":"R1","unstructured":"Forno LS. The Lewy body in Parkinson\u2019s disease.Adv Neurol1987; 45: 35\u201343."},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis.Science1983; 219: 979\u201380.","DOI":"10.1126\/science.6823561"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Lansbury PT, Brice A. Genetics of Parkinson\u2019s disease and biochemical studies of implicated gene products.Curr Opin Genet Dev2002; 12: 299\u2013306.","DOI":"10.1016\/S0959-437X(02)00302-7"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Lotharius J, Brundin P. Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alphasynuclein.Nat Rev Neurosci2002; 3: 932\u201342.","DOI":"10.1038\/nrn983"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Kahle PJ, Haass C, Kretzschmar HA, Neumann M\/Sn\u00b0 5, vol. 19, mai 2003M. Structure\/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson\u2019s and related diseases.J Neurochem2002; 82: 449\u201357.","DOI":"10.1046\/j.1471-4159.2002.01020.x"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Spillantini MG, Schmidt ML, Lee VM,et al.Alphasynuclein in Lewy bodies.Nature1997; 388: 839\u201340.","DOI":"10.1038\/42166"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Kirik D, Rosenblad C, Burger C,et al.Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.J Neurosci2002; 22: 2780\u201391.","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Klein RL, King MA, Hamby ME, Meyer EM. Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra.Hum Gene Ther2002; 13: 605\u201312.","DOI":"10.1089\/10430340252837206"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P. Alphasynucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson\u2019s disease.Proc Natl Acad Sci USA2002; 99: 10813\u20138.","DOI":"10.1073\/pnas.152339799"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Xu J, Kao SY, Lee FJ,et al.Dopamine-dependent neurotoxicity of alphasynuclein: a mechanism for selective neurodegeneration in Parkinson disease.Nat Med2002; 8: 600\u20136.","DOI":"10.1038\/nm0602-600"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopaminealpha- synuclein adduct.Science2001; 294: 1346\u20139.","DOI":"10.1126\/science.1063522"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Conway KA, Lee SJ, Rochet JC,et al.Acceleration of oligomerization, not fibrillization, is a shared property of both alphasynuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy.Proc Natl Acad Sci USA2000; 97: 571\u20136.","DOI":"10.1073\/pnas.97.2.571"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations.Nature2002; 418: 291.","DOI":"10.1038\/418291a"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Shimura H, Hattori N, Kubo S,et al.Familial Parkinson disease gene product, parkin, is a ubiquitinprotein ligase.Nat Genet2000; 25: 302\u20135.","DOI":"10.1038\/77060"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Shimura H, Schlossmacher MG, Hattori N,et al.Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson\u2019s disease.Science2001; 293: 263\u20139.","DOI":"10.1126\/science.1060627"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Giasson BI, Lee VM. Parkin and the molecular pathways of Parkinson\u2019s disease.Neuron2001; 31: 885\u20138.","DOI":"10.1016\/S0896-6273(01)00439-1"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT. TheUCH-L1gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson\u2019s disease susceptibility.Cell2002; 111: 209\u201318.","DOI":"10.1016\/S0092-8674(02)01012-7"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Bonifati V, Rizzu P, van Baren MJ,et al.Mutations in theDJ-1gene associated with autosomal recessive early-onset parkinsonism.Science2003; 299: 256\u20139.","DOI":"10.1126\/science.1077209"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2003195613\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T22:04:17Z","timestamp":1560031457000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2003195613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":18,"journal-issue":{"issue":"5"},"alternative-id":["medsci2003195p613"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2003195613","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}